| P/E (FY) | — | Sales (TTM) | €509.9M |
| Earnings (TTM) | €104.0M | ROE | 38.58% |
| Net Margin | 20.40% | ROIC | 10.68% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 15.97% |
GPI S.p.A. provides social-healthcare and information technology services in Italy and internationally. Its offerings include population health management, healthcare administration and accounting, hospital and clinical information systems, laboratory and diagnostic imaging systems, transfusion systems, virtual care, and pharmacy automation. The company also supplies management systems for public administration, cybersecurity, artificial intelligence, interoperability, data analytics, and wearable technologies. Founded in 1988, it is headquartered in Trento, Italy.
| Market Cap | — | Trading Days | 2742 |
| 52W High | 18.68 |
| 52W Low | 13.28 |
| % Off High | −28.80% |
| YTD | −12.92% | 1Y | −11.02% |
| 3Y | 36.79% | 5Y | 25.39% |
| 10Y | 85.03% | Since incept. (ann.) | 6.05% |
| Ann. Volatility (1Y) | 32.96% | Ann. Volatility (3Y) | 39.99% |
| Sharpe (1Y) | −0.19 | Sharpe (3Y) | 0.46 |
| Max Drawdown (1Y) | −24.79% | Max Drawdown (3Y) | −36.18% |
| Beta (3Y, vs SPY) | 1.02 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| LLY | ELI LILLY & Co | $1.14T | 52.7 |
| JNJ | JOHNSON & JOHNSON | $639.90B | 24.1 |
| ONC | BeOne Medicines Ltd. | $472.90B | 1722.2 |
| ABBV | AbbVie Inc. | $465.20B | 111.6 |
| MRK | Merck & Co., Inc. | $321.97B | 17.9 |
| AMGN | AMGEN INC | $209.21B | 27.2 |
| ABT | ABBOTT LABORATORIES | $188.12B | 29.0 |
| GILD | GILEAD SCIENCES, INC. | $164.79B | 19.6 |
| PFE | PFIZER INC | $143.34B | 18.5 |
| SYK | STRYKER CORP | $135.04B | 41.9 |
| BMY | BRISTOL MYERS SQUIBB CO | $128.85B | 18.2 |
| ISRG | INTUITIVE SURGICAL INC | $124.74B | 44.9 |
